DrugPatentWatch Database Preview
Drugs in Development Information for PSN-375,963
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug PSN-375,963?
PSN-375,963 is an investigational drug.
There have been 6 clinical trials for PSN-375,963.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2008.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Neurotoxicity Syndromes, and Leukemia, Myeloid. The leading clinical trial sponsors are Sanofi, Western University, Canada, and University of Toronto.
Summary for PSN-375,963
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 25 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2008-01-01) |
| Vendors | 10 |
Recent Clinical Trials for PSN-375,963
| Title | Sponsor | Phase |
|---|---|---|
| Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study | University of Alberta | N/A |
| Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study | University of Toronto | N/A |
| Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study | Western University, Canada | N/A |
Clinical Trial Summary for PSN-375,963
Top disease conditions for PSN-375,963
Top clinical trial sponsors for PSN-375,963
US Patents for PSN-375,963
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
